NASDAQ: INDP
Indaptus Therapeutics Inc Stock Ownership - Who owns Indaptus Therapeutics?

Insider buying vs selling

Have Indaptus Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jeffrey A. MecklerChief Executive Officer2025-07-276,068$8.30
$50.38kBuy

1 of 1

INDP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INDP insiders and whales buy or sell their stock.

INDP Shareholders

What type of owners hold Indaptus Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Dexcel Pharma Technologies Ltd241.83%4,234,897$11.22MInsider
Michael James Newman78.14%1,368,356$3.63MInsider
Glen R. Anderson74.48%1,304,318$3.46MInsider
John W. Kozarich8.67%151,761$402.17kInsider
Anthony J. Maddaluna3.06%53,570$141.96kInsider
Nadav Navon1.11%19,456$51.56kInsider
Virtu Financial LLC1.08%18,997$50.34kInstitution
Jeffrey A. Meckler0.76%13,312$35.28kInsider
Gil Bianco0.57%10,000$26.50kInsider
Issac Silberman0.23%4,000$10.60kInsider

1 of 2

INDP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INDP0.28%99.72%Net Buying
GLMD1.33%0.00%
MTNB0.98%99.02%
XBIO1.41%98.59%
GNPX20.95%79.05%Net Selling

Indaptus Therapeutics Stock Ownership FAQ

Who owns Indaptus Therapeutics?

Indaptus Therapeutics (NASDAQ: INDP) is owned by 1.14% institutional shareholders, 408.93% Indaptus Therapeutics insiders, and 0.00% retail investors. Dexcel Pharma Technologies Ltd is the largest individual Indaptus Therapeutics shareholder, owning 4.23M shares representing 241.83% of the company. Dexcel Pharma Technologies Ltd's Indaptus Therapeutics shares are currently valued at $11.22M.

If you're new to stock investing, here's how to buy Indaptus Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.